Soc. Generale Discount Zert PBB 3.../ DE000SW1PKS8 /
14/06/2024 08:47:03 | Var.-0.010 | Denaro09:01:22 | Lettera- | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
4.920EUR | -0.20% | 4.900 Quantità in denaro: 2,100 |
- Quantità in lettera: - |
DT.PFANDBRIEFBK AG | - EUR | 31/12/2024 | Call |
GlobeNewswire
09:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
09:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
09:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
09:00
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
08:00
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
07:00
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...